Publikasi Scopus 2010 s/d 2022

Margiana R., Alsaikhan F., Al-Awsi G.R.L., Patra I., Sivaraman R., Fadhil A.A., AL-Baghdady H.F.A., Qasim M.T., Hameed N.M., Mustafa Y.F., Hosseini-Fard S.
56685900600;40460917700;57202305366;57226894791;57216885702;57809112500;57210748753;57209829639;57196369598;57203725947;57908446700;
Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in atherosclerosis
2022
Cellular Signalling
100
110471
2
Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Master's Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Dr. Soetomo General Academic Hospital, Jakarta, Surabaya, Indonesia; College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia; Department of Radiological Techniques, Al-Mustaqbal University College, Babylon, Hillah, 51001, Iraq; An Independent Researcher, PhD from NIT Durgapur, West Bengal, Durgapur, India; Dwaraka Doss Goverdhan Doss Vaishnav College, University of Madras, Arumbakkam, Chennai, India; College of Medical Technology, Medical Lab techniques, Al-farahidi University, Iraq; College of Dentistry, the Islamic University, Najaf, Iraq; Department of Anesthesia, College of Health and Medical Technololgy, Al-Ayen University, Thi-Qar, Iraq; Anesthesia techniques, Al–Nisour University College, Baghdad, Iraq; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq; Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Margiana, R., Department of Anatomy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Master's Programme Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Dr. Soetomo General Academic Hospital, Jakarta, Surabaya, Indonesia; Alsaikhan, F., College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia; Al-Awsi, G.R.L., Department of Radiological Techniques, Al-Mustaqbal University College, Babylon, Hillah, 51001, Iraq; Patra, I., An Independent Researcher, PhD from NIT Durgapur, West Bengal, Durgapur, India; Sivaraman, R., Dwaraka Doss Goverdhan Doss Vaishnav College, University of Madras, Arumbakkam, Chennai, India; Fadhil, A.A., College of Medical Technology, Medical Lab techniques, Al-farahidi University, Iraq; AL-Baghdady, H.F.A., College of Dentistry, the Islamic University, Najaf, Iraq; Qasim, M.T., Department of Anesthesia, College of Health and Medical Technololgy, Al-Ayen University, Thi-Qar, Iraq; Hameed, N.M., Anesthesia techniques, Al–Nisour University College, Baghdad, Iraq; Mustafa, Y.F., Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq; Hosseini-Fard, S., Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Nowadays, emerging data demonstrate that the toll-like receptor (TLR) signaling pathway plays an important role in the progression of inflammatory atherosclerosis. Indeed, dysregulated TLR signaling pathway could be a cornerstone of inflammation and atherosclerosis, which contributes to the development of cardiovascular diseases. It is interesting to note that this pathway is heavily controlled by several mechanisms, such as epigenetic factors in which the role of non-coding RNAs (ncRNAs), particularly microRNAs and long noncoding RNAs as well as circular RNAs in the pathogenesis of atherosclerosis has been well studied. Recent years have seen a significant surge in the amount of research exploring the interplay between ncRNAs and TLR signaling pathway downstream targets in the development of atherosclerosis; however, there is still considerable room for improvement in this field. The current study was designed to review underlying mechanisms of TLR signaling pathway and ncRNA interactions to shed light on therapeutic implications in patients with atherosclerosis. © 2022
Atherosclerosis; circRNAs; Inflammation; lncRNA; miRNA; ncRNA; TLR signaling
alirocumab; anakinra; antisense oligonucleotide; atorvastatin; azd 8233; bermekimab; canakinumab; colchicine; evolocumab; ezetimibe; fluindostatin; hydroxymethylglutaryl coenzyme A reductase inhibitor; immunoglobulin enhancer binding protein; mevinolin; mitogen activated protein kinase; myeloid differentiation factor 88; pitavastatin; pravastatin; rosuvastatin; simvastatin; tocilizumab; toll like receptor; tumor necrosis factor receptor associated factor 6; untranslated RNA; aminotransferase blood level; atherosclerosis; gene function; gene interaction; genetic association; human; hyperglycemia; muscle toxicity; nonhuman; protein function; Review; side effect; ST segment elevation myocardial infarction; TLR signaling
The authors thanks Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding project number ( IF-PSAU-2021/03/19040 ).
Elsevier Inc.
08986568
36122884
Review
Q2
1167
3195